Biotech / Finance

Cell Medica raises £60m to advance multiple cancer programmes

From PBR - News
March 17, 2017 - 2:25am
Cellular immunotherapy company, Cell Medica has secured £60m in a Series C financing round with participation from existing investors Touchstone Innovations, funds managed by Woodford Investment Management, and funds managed by Invesco Perpetual.

Continue reading this article »